Total Hip, Lord Madreporic
510(k) K780330
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK780330 | Date12 May 1978 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- KWA
- Device Class
- Class III
- Regulation
- 21 CFR Part 888.3330
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
This device is a Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component) as classified under FDA nomenclature. It is designed as a metal acetabular component for use in total hip arthroplasty, featuring an uncemented design for fixation to the pelvis without bone cement.
The Lord Madreporic Total Hip is supplied as a reusable surgical implant, intended for use in orthopedic procedures. It is regulated under FDA 510(k) clearance (K780330) and falls under Class III medical device classification. Multiple FEI numbers (e.g., 3020282716) reference specific variants, though no details on sterility, MRI safety, or storage conditions are provided in the data.
Other devices from Howmedica Corp.
Questions
AI-generated answers, 18 Sep 2026
What types of orthopedic procedures is the Lord Madreporic Total Hip designed for, and how does its uncemented design benefit patients?
The Lord Madreporic Total Hip is specifically designed for total hip arthroplasty procedures, where it serves as a semi-constrained metal acetabular component. Its uncemented design allows for direct fixation to the pelvis without the use of bone cement, which can reduce risks associated with cement-related complications like loosening or inflammation. This approach may also promote better bone integration over time, potentially improving long-term stability and durability.
Is the Lord Madreporic Total Hip reusable or single-use, and what does that mean for surgical planning?
The Lord Madreporic Total Hip is explicitly described as a reusable surgical implant. This means it is intended to be sterilized and reused for multiple procedures, which can help control costs and reduce waste. However, surgical planning must account for proper sterilization protocols to ensure patient safety between uses, as well as inventory management to maintain availability for procedures.
Are there multiple sizes or models available for the Lord Madreporic Total Hip, and how might a clinician determine the appropriate fit for a patient?
The data references multiple FEI numbers (e.g., 3020282716), which typically correspond to different variants or sizes of the device. While specific measurements or sizing details are not provided, these variants likely cater to different patient anatomies or surgical needs. Clinicians would typically rely on preoperative imaging and sizing guides provided by the manufacturer to select the appropriate acetabular component for a patient’s unique pelvic structure.
What regulatory pathway was followed for the Lord Madreporic Total Hip, and what does that mean for its use in clinical practice?
The Lord Madreporic Total Hip was cleared through the FDA’s 510(k) pathway, specifically under the traditional review process, and is classified as a Class III medical device. This classification indicates it carries higher regulatory scrutiny due to its role in supporting life-sustaining or life-sustaining procedures. The clearance (K780330) confirms it was deemed substantially equivalent to a legally marketed predicate device at the time of submission, ensuring it meets FDA standards for safety and effectiveness in total hip arthroplasty procedures.